{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidvbprqmsrq52347oycxxh655swwsqohuyur26gtqja5fiucj5rke",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3me6v4yjyyhu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicpxpy76vyhmfqbbrxzeohmry5zhy46x3wq627ssfwr753hd4rs6u"
    },
    "mimeType": "image/jpeg",
    "size": 1750
  },
  "path": "/story/383255/rivals-cheaper-glp-1-pill-rattles-novo-nordisk-eli-lilly.html",
  "publishedAt": "2026-02-06T05:41:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "In a direct challenge to the booming obesity-drug business, telehealth company Hims & Hers has rolled out what it says is the cheapest GLP-1 weight-loss pill in the US—and it's already rattling Wall Street and one of the industry's biggest players. The online platform is offering compounded oral semaglutide...",
  "title": "Rival's Cheaper GLP-1 Pill Rattles Novo Nordisk, Eli Lilly"
}